Andas

Jubilant Life receives USFDA nod for hypertension tablets

As on 30 June, 2016, Jubilant Life Sciences had a total of 770 filings for Oral Solids of which 578 have been approved in various regions globally

Zydus Healthcare strengthens US portfolio with 2 ANDA buys from Teva

The company said these ANDAs have been acquired by its 100 per cent subsidiary, Zydus Worldwide DMCC and will be financed through the group's internal accruals

US agencies knock bottom out of Ranbaxy's future blockbusters

Ranbaxy's future blockbuster drugs may have been compromised by a settlement with US prosecutors for sale of adulterated drugs